West Nile Virus Antibody, Equine OriginThis page contains information on West Nile Virus Antibody, Equine Origin for veterinary use.
The information provided typically includes the following:
- West Nile Virus Antibody, Equine Origin Indications
- Warnings and cautions for West Nile Virus Antibody, Equine Origin
- Direction and dosage information for West Nile Virus Antibody, Equine Origin
West Nile Virus Antibody, Equine OriginThis treatment applies to the following species:
Concentrated / Purified
Directions For Use
This product has a 21 day withdrawal period. Warm to body temperature before use. Use entire contents when first opened. Store at 2° to 7° C. Do not freeze. Do not mix with other products.
Anaphylactoid reaction, which occurs rarely, should be treated with administration of adrenalin or equivalent. A condition referred to as “serum hepatitis” has been associated infrequently with the use of biologics containing equine serum. Safety of repeated injections and use in pregnant animals have not been established.
DOSAGE & ADMINISTRATION:
Product is for I.V. administration and may be given undiluted or diluted in Sterile Lactated Ringers Solution. Administer 10 ml per 100 lbs of body weight using a sterile I.V. catheter.
For use in one year or older horses for treatment of disease caused by West Nile Virus.
For use by or under the supervision of a veterinarian. The product license is conditional. Efficacy and potency test studies in progress.
Contains thimerosal as a preservative.
FOR VETERINARY USE ONLY
THE PEAK OF QUALITY
VLN: 188 / PCN: 3995.00
PROFESSIONAL BIOLOGICAL COMPANY, 4950 York Street, Denver, Colorado 80216
50 ml, 100 ml
4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216
|Every effort has been made to ensure the accuracy of the West Nile Virus Antibody, Equine Origin information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2019 Animalytix LLC. Updated: 2019-09-30